Filing Flows › HealthLynked (HLYK) › Q1 2026 › vs Q1 2025
HealthLynked (HLYK) Q1 2026 vs Q1 2025 (year over year)
HealthLynked's revenue fell $351K (-45%) from $774K in Q1 2025 to $423K in Q1 2026. The biggest changes: Patent Service Revenue Net −$345K (-45%); Product and Other Revenue −$11K (-89%); Subscription and Event Revenue −$6K (-64%).
HealthLynked, Q1 2026: revenue $423K (-45% year over year), operating margin -165.5%, net loss $1.6M, operating cash flow −$222K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Patient Service Revenue Net | $419K | $752K | −$333K | -44% |
| Product Revenue | $1K | $13K | −$11K | -89% |
| Patent Service Revenue Net | $420K | $765K | −$345K | -45% |
| Subscription and Event Revenue | $3K | $10K | −$6K | -64% |
| Product and Other Revenue | $1K | $13K | −$11K | -89% |
| Revenue | $423K | $774K | −$351K | -45% |
| Net loss | $1.6M | $1.1M | $570K | +54% |
| Costs & expenses | $2.0M | $1.8M | $220K | +12% |
| Operating costs | $1.1M | $1.4M | −$267K | -19% |
| Interest & other, net | $920K | $434K | $487K | +112% |
| SG&A | $847K | $629K | $218K | +35% |
| Other operating costs | $277K | $762K | −$485K | -64% |
| Operating cash sources | $1.6M | $1.1M | $570K | +54% |
| Depreciation | $26K | $28K | −$2K | -7% |
| Share-based compensation | $298K | $7K | $290K | 42× |
| Working capital & other | $1.1M | $583K | $493K | +84% |
| Cash used in operations | $222K | $433K | −$211K | -49% |
| Net loss absorbed | $1.6M | $1.1M | $570K | +54% |
Questions
How much did HealthLynked's revenue grow year over year in Q1 2026?
HealthLynked's revenue fell $351K (-45%) from $774K in Q1 2025 to $423K in Q1 2026.
What drove HealthLynked's revenue change in Q1 2026?
Patent Service Revenue Net −$345K (-45%); Product and Other Revenue −$11K (-89%); Subscription and Event Revenue −$6K (-64%).